Drug interactions
 - Ignoring Drug Interactions for the Right Reasons
John R. Horn, PharmD, FCCP, and Philip D. Hansten, PharmD - The Effect of Hepatic Disease on Drug Interactions
John R. Horn, PharmD, FCCP, and Philip D. Hansten, PharmD - New Oxycodone Drug Interactions
John R. Horn, PharmD, FCCP, and Philip D. Hansten, PharmD - Drug Interactions: Interactions Involving Drugs That Prolong the QTc Interval
John R. Horn, PharmD, FCCP, and Philip D. Hansten, PharmD - Tramadol and Serotonin Syndrome
John R. Horn, PharmD, FCCP, and Philip D. Hansten, PharmD - More Evidence of a Warfarin-Antibiotic Interaction
John R. Horn, PharmD, FCCP, and Philip D. Hansten, PharmD - The Dangers of Beta-Blockers and Epinephrine
John R. Horn, PharmD, FCCP, and Philip D. Hansten, PharmD - Drug Interactions: Beware of CYP2D6 Inhibitors in Patients Taking Tamoxifen
John R. Horn, PharmD, FCCP, and Philip Hansten, PharmD - Drug Transporters: The Final Frontier for Drug Interactions—Part 2
John R. Horn, PharmD, FCCP, and Philip Hansten, PharmD - Drug Interactions: Interaction Decisions: Using Evidence to Weigh Risks
John R. Horn, PharmD, FCCP, and Philip Hansten, PharmD - Drug Transporters: The Final Frontier for Drug Interactions
John R. Horn, PharmD, FCCP, and Philip Hansten, PharmD - Drugs That Inhibit Levothyroxine Absorption
John R. Horn, PharmD, FCCP, and Philip Hansten, PharmD - Protease Inhibitors and PPIs
John R. Horn, PharmD, FCCP, and Philip D. Hansten, PharmD - Get to Know an Enzyme: CYP3A4
John R. Horn, PharmD, FCCP, and Philip D. Hansten, PharmD - Prescribers' Knowledge of Drug Interactions
John R. Horn, PharmD, FCCP, and Philip D. Hansten, PharmD
|
|
|
|
|
Inside the Issue
